Results 151 to 160 of about 12,567 (213)

Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 2023-2033, June 2025.
Abstract Aims Dapagliflozin (DAPA), a sodium‐glucose co‐transporter 2 inhibitor, has been shown to reduce cardiovascular mortality among patients with chronic heart failure. We aimed to evaluate the impact on a worsening renal function (WRF) by adding DAPA as compared to standard decongestive therapy with loop diuretics alone.
Shodai Kawanami, Yasuyuki Egami, Masaru Abe, Mizuki Osuga, Hiroaki Nohara, Kohei Ukita, Akito Kawamura, Koji Yasumoto, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino   +11 more
wiley   +1 more source

Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment. [PDF]

Korean J Intern Med
Kim SE, Yoo BS.
europepmc   +1 more source

Association between the Tpeak‐Tend interval on admission and coronary microvascular dysfunction in Takotsubo syndrome

ESC Heart Failure, Volume 12, Issue 3, Page 2047-2056, June 2025.
Abstract Aims The Tpeak‐Tend interval on electrocardiogram may be a predictor of worse outcomes in Takotsubo syndrome (TTS), but the mechanisms have not been fully determined. This study aimed to investigate the relationships between the corrected Tpeak‐Tend (cTp‐e) interval and coronary microvascular‐dysfunction (CMD) assessed by the angiography ...
Kyohei Onishi, Masafumi Ueno, Nobuhiro Yamada, Kazuyoshi Kakehi, Kosuke Fujita, Koichiro Matsumura, Gaku Nakazawa   +6 more
wiley   +1 more source

Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity. [PDF]

J Clin Med Res
Okamura K, Matsushima M, Takamiya Y, Okuda T, Sako H, Udo A, Taniguchi K, Morisaki S, Imamura I, Urata H, Miura SI.   +10 more
europepmc   +1 more source

The efficacy and safety of sodium‐glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 2087-2097, June 2025.
Abstract Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i) have demonstrated effectiveness in reducing cardiovascular death and heart failure hospitalization (HFH). However, the efficacy and safety of SGLT2 inhibitors in elderly patients with poor general status, such as very low bodyweight or low nutritional status, who are not included ...
Kenji Nakano, Kenji Kanenawa, Akihiro Isotani, Takashi Morinaga, Kaori Yamamoto, Norihisa Miyawaki, Euihong Ko, Miho Nakamura, Yuichi Tanaka, Kenichi Ishizu, Toru Morofuji, Masaomi Hayashi, Masato Fukunaga, Makoto Hyodo, Shinichi Shirai, Kenji Ando   +15 more
wiley   +1 more source

A Systematic Review and Meta-Analysis of an Angiotensin Receptor-Neprilysin Inhibitor in Patients Using a Durable Left Ventricular Assist Device. [PDF]

J Clin Med
Hasabo EA, Isik B, Elgadi A, Yacoub MS, Bakr MS, Eljack MMF, Sultan S, Caliskan K, Soliman O.   +8 more
europepmc   +1 more source

Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure—A prospective cohort study

ESC Heart Failure, Volume 12, Issue 3, Page 2113-2124, June 2025.
The prognostic impact of the muscle parameters gait speed, handgrip strength and appendicular skeletal muscle index on cardiovascular outcomes was investigated. We prospectively analyzed a cohort of 205 heart failure patients with a median left ventricular ejection fraction of 37% and a median follow‐up of 4.7 years.
Vladimir Cejka, Hermann Riepl, Nora Schwegel, Ewald Kolesnik, David Zach, Viktoria Santner, Viktoria Höller, Natascha Schweighofer, Barbara Obermayer‐Pietsch, Thomas Pieber, Caroline Morbach, Stefan Frantz, Andreas Zirlik, Dirk von Lewinski, Stefan Störk, Florian Posch, Klemens Ablasser, Nicolas Verheyen   +17 more
wiley   +1 more source

Impact of the hemoglobin-to-red cell distribution width ratio on 30-day readmission in patients with heart failure. [PDF]

BMC Cardiovasc Disord
He Z, Zheng C, Chen M, Chen T, Huang F, Zhu Z, He Y, Li M.   +7 more
europepmc   +1 more source

SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices

ESC Heart Failure, Volume 12, Issue 3, Page 2125-2133, June 2025.
Abstract Background Sodium glucose cotransporter 2 inhibitors (SGLT2i) represent one of the four pillars of heart failure (HF) pharmacological therapy. Objective The study aims to clarify SGLT2i antiarrhythmic effect on patients with HF with reduced ejection fraction (HFrEF) in terms of atrial and ventricular arrhythmias (AAs and VAs) reduction ...
Marco Valerio Mariani, Carlo Lavalle, Marta Palombi, Nicola Pierucci, Sara Trivigno, Andrea D'Amato, Domenico Filomena, Pietro Cipollone, Domenico Laviola, Agostino Piro, Silvia Prosperi, Josefina Magliolo, Vincenzo Myftari, Vincenzo Mirco La Fazia, Paolo Severino, Cristina Chimenti, Roberto Badagliacca, Carmine Dario Vizza   +17 more
wiley   +1 more source

Sacubitril-Valsartan Lowers Blood Pressure in Patients on Dialysis: A Randomized Controlled Multicenter Study. [PDF]

Kidney Dis (Basel)
Lin L, Bian W, Luo Q, Wang L, Liu N, Yang M, Cen J, Cai K, Hua J, Gu H, Qi H, Wang Z, Niu J, Chen Y, Gu Y, Hu C, Li S, Li Y, Chen N, Li X.   +19 more
europepmc   +1 more source